Login / Signup

Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis.

Aftab UllahGang ChenAbid HussainHanif KhanAzar AbbasZhanwei ZhouMuhammad ShafiqSaleem AhmadUsman AliMuhammad UsmanFaisal RazaAbrar AhmedZijie QiuMaochao ZhengDaojun Liu
Published in: International journal of nanomedicine (2021)
Our findings validate the feasibility of using PEI-Cyclam as a siRNA delivery vector for simultaneous TGFβ siRNA delivery and CXCR4 inhibition for the combined anti-fibrotic effects in a setting of CCl4-induced liver fibrosis.
Keyphrases
  • liver fibrosis
  • high glucose
  • cancer therapy
  • diabetic rats
  • transforming growth factor
  • hyaluronic acid
  • drug delivery
  • signaling pathway
  • epithelial mesenchymal transition
  • combination therapy
  • replacement therapy